Dr. Lal PathLabs has informed about schedule of Analyst/ Institutional Investor Meetings pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations 2015.
The above information is a part of company’s filings submitted to BSE.